In the early stages of oncogenesis, transient activation of Nrf2 can exert tumor-suppressive effects by enhancing the antioxidant response, limiting genomic instability, and promoting the elimination of transformed or damaged cells. This evidence concerns the gene NFE2L2 and neoplasm.